Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Kanda

Showing results (341-350 of 390) with videos related to

Pageof 39
Sort By:
Journal of Chemotherapy (Florence, Italy)|October 16, 2014
Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphomaMisato Kikuchi, Hideki Nakasone, Yu Akahoshi, et al.
Transplantation and Cellular Therapy|October 2, 2020
Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter AnalysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Annals of Hematology|April 14, 2026
Donor selection for patients with HLA-homozygous haplotypes in allogeneic hematopoietic stem cell transplantationNoriyoshi Yoshinaga, Makoto Iwasaki, Koji Kato, et al.
Blood Advances|December 21, 2021
Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learningMakoto Iwasaki, Junya Kanda, Yasuyuki Arai, et al.
Leukemia|June 1, 2019
Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Transplantation Proceedings|February 9, 2024
Comparative Analysis of Allogeneic Bone Marrow Transplantation Outcomes Between Japanese and Non-Japanese PopulationsRyu Yanagisawa, Michiho Shindo, Akihito Shinohara, et al.
Blood|January 12, 2012
Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort studyJunya Kanda, Masakatsu Hishizawa, Atae Utsunomiya, et al.
International Journal of Hematology|February 13, 2015
Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantationMiki Sato, Shinichi Kako, Kana Matsumoto, et al.
Transplantation and Cellular Therapy|March 8, 2023
Effect of Graft-versus-Host Disease on Post-Transplantation Outcomes following Single Cord Blood Transplantation Compared with Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Adult Acute Myeloid LeukemiaTakaaki Konuma, Kensuke Matsuda, Yoshimitsu Shimomura, et al.
American Journal of Hematology|October 29, 2025
Platelet Recovery and Its Impact on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Nationwide Retrospective StudyNaoki Kurita, Kazushi Maruo, Fumihiko Kimura, et al.
Pageof 39

Showing results (341-350 of 390) with videos related to

Sort By:
Pageof 39
Journal of Chemotherapy (Florence, Italy)|October 16, 2014
Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphomaMisato Kikuchi, Hideki Nakasone, Yu Akahoshi, et al.
Transplantation and Cellular Therapy|October 2, 2020
Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter AnalysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Annals of Hematology|April 14, 2026
Donor selection for patients with HLA-homozygous haplotypes in allogeneic hematopoietic stem cell transplantationNoriyoshi Yoshinaga, Makoto Iwasaki, Koji Kato, et al.
Blood Advances|December 21, 2021
Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learningMakoto Iwasaki, Junya Kanda, Yasuyuki Arai, et al.
Leukemia|June 1, 2019
Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Transplantation Proceedings|February 9, 2024
Comparative Analysis of Allogeneic Bone Marrow Transplantation Outcomes Between Japanese and Non-Japanese PopulationsRyu Yanagisawa, Michiho Shindo, Akihito Shinohara, et al.
Blood|January 12, 2012
Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort studyJunya Kanda, Masakatsu Hishizawa, Atae Utsunomiya, et al.
International Journal of Hematology|February 13, 2015
Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantationMiki Sato, Shinichi Kako, Kana Matsumoto, et al.
Transplantation and Cellular Therapy|March 8, 2023
Effect of Graft-versus-Host Disease on Post-Transplantation Outcomes following Single Cord Blood Transplantation Compared with Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Adult Acute Myeloid LeukemiaTakaaki Konuma, Kensuke Matsuda, Yoshimitsu Shimomura, et al.
American Journal of Hematology|October 29, 2025
Platelet Recovery and Its Impact on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Nationwide Retrospective StudyNaoki Kurita, Kazushi Maruo, Fumihiko Kimura, et al.
Pageof 39